AbstractThe CD27 membrane antigen is exclusively present on a large subset of human peripheral blood T lymphocytes and on mature thymocytes. Several observations point towards a specific role of this molecule on activated T cells. Upon T cell activation induced via the T cell receptor complex, CD27 expression greatly increases, while addition of anti‐CD27 monoclonal antibodies amplifies the proliferative response. Within the CD4 subset, only CD27 T cells provide helper activity for B cell differentiation. Interestingly, CD27 expression differs not only quantitatively, but also qualitatively between resting and activated T cells. On resting cells, CD27 is a disulfide‐linked homodimer with subunits of 55 kDa molecular mass. Upon activation, also a 55‐kDa monomer seems to occur, while in addition a 32‐kDa component is found. The relationship between these two proteins has been investigated. The 55‐kDa and 32‐kDa molecules do not seem to be physically associated. The two CD27 components are structurally highly homologous as determined by two‐dimensional mapping of tryptic peptides. They both express the epitopes recognized by anti‐CD27 antibodies, indicating that the 32‐kDa molecule is also T cell specific. Both 55‐kDa and 32‐kDa molecules carry N‐linked carbohydrate groups. However, they differ in other, not yet specified, post‐translational modifications, and do not arise from a common precursor simply by alternative N‐glycosylation. The 32‐kDa form may be derived by proteolytic processing from the 55‐kDa protein, but most likely not from a larger (common) precursor. Alternatively, both molecules may arise from a common gene by alternative mRNA splicing, or be derived from highly homologous genes. The dramatic change in molecular composition of CD27 suggests a newly acquired function for CD27 on activated T cells.